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Abstract
A streamlined entry into the sesquiterpene lactones (SQL) cores of linearifolin and zaluzanin A is
described. Stereochemistry is controlled through transformations uncovered by ISES (In-Situ-
Enzymatic-Screening). Absolute stereochemistry derives from kinetic resolution of 5-
benzyloxypentene-1,2-oxide, utilizing a β-pinene-derived-Co(III)-salen. Relative stereochemistry
(1,3-cis-fusion)is set via formal halometalation/carbocyclization, mediated by [Rh(O2CC3F7)2]2/
LiBr. Subsequent ring-closing metathesis (RCM-Grubbs II) yields the title exomethylene-δ-
lactone SQL-cores. In complementary fashion, RCM with Grubbs-I catalyst provides the
oxabicyclo[3.3.1]nonyl-core of xerophilusin R and zinagrandinolide.
ISES (In Situ Enzymatic Screening)-assisted catalyst development has led to the (i)
discovery of the first asymmetric Ni(0)-mediated allylic amination chemistry,1 (ii) new
halometalation/carbocyclization transformations2 and (iii) the identification of novel chiral
salen ligands for asymmetric catalysis.3 This Letter describes the deployment of the latter
two methods for stereocontrolled entry into bicyclic terpenoid natural product (NP) cores
bearing a reactive exomethylene δ-lactone functionality.
This functional group has been linked to NFKB-inhibition via active site cysteine capture,
leading Merfort to propose a QSAR model for NFKB inhibition/anti-cancer activity in such
sesquiterpene lactones (SQLs).4 Against this medicinal chemistry backdrop there has been
vigorous synthetic activity in the exomethylene SQL area,5 including approaches that permit
core synthesis6 and chain extension.7 While a number of routes focus on end game
methylenation,8 we favored a convergent strategy in which a formal halometalation/
carbocyclization would at once close the lactone, control ring fusion geometry, and set in
place the reactive, conjugated exomethylene moiety.2 This approach has an added benefit
for chemical biology; as the resultant β-bromo-α, β-unsaturated carbonyl system should be
advantageous for library generation.9
dbb@unlserve.unl.edu.
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Targeted herein are the cores of SQLs carrying this functionality within a bridged
oxabicyclo[4.3.1]decyl framework, as in linearifolin angelate10 (Fig. 1; from H.
linearifolium, related to fastigilin A, a potent anti-neoplastic agent)11 and zaluzanin A
(muscle relaxant).12
Interestingly, these two terpenoid lactone cores have opposite handedness, therefore
efficient hydrolytic kinetic resolution (HKR)3, 13 should allow for assembly of both cores
from a common racemic epoxide building block precursor (Fig. 2), one from the diol
product (as the cyclic sulfate), the other from the remaining epoxide. Such a convergent
sequence would both allow for the efficient assembly of the exomethylene δ-lactone and set
the cis-1,3-fusion stereochemistry in the key halometalation-carbocyclization step, a
transformation for which both Rh-perfluorocarboxylate and Pd(II) catalysts have been
uncovered recently in our lab.2,14
Toward this end, an improved ISES screen [Fig. 3-new KRED (ketoreductase) enzymes15]
identified salen 4a catalyst, assembled from the β-pinene-derived diamine and α-hydroxy-β-
naphthaldehyde, in its Co(III)-OAc form as a generally (S)-selective catalyst for terminal
epoxides. This KRED assay has advantages over the previously reported hexene oxide
screen;3a as the two reporting enzymes show opposite enantioselectivities (see Supporting
Information) and both are readily available. For the synthesis at hand, efficient HKR of an
O-protected 5-hydroxy-1,2-pentene oxide was desired. Accordingly, a series of such
potential building blocks were screened for HKR with Co(III)-4a-OAc. As can be seen
(Table 1), this catalyst is generally (S)-selective for substrates bearing arylmethyl ether
protecting groups.
In the event, when racemic 9 was treated with Co(III)-4a-OAc, on a 13 g scale, both
antipodal building blocks, (R)-epoxide 9b and (S)-diol 12 were obtained in high ee (Scheme
1) attesting to the potential3a of this new chiral salen in asymmetric catalysis. The diol was
easily converted to the corresponding cyclic sulfate 13.
As is illustrated in Scheme 2, the requisite 3-carbon allylic carbonate “acceptor”
functionality for the carbocyclization could be installed via cyclic sulfate opening with a
lithiated propargyl ether. Lindlar semi-hydrogenation and unveiling of the masked terminal
olefin, was followed by selective carbonylation of the primary alcohol. The propiolate
moiety then enters with Mitsunobu inversion at the HKR-derived stereocenter.
The title bromorhodiation/carbocylization was carried out on 18a,2 crafting both the Z-
configured C-Br bond and the ring-forming C-C bond, thereby setting in place the requisite
cis-1,3-ring fusion in 19a. Moreover, a detailed study (50 mg scale) showed that yields
could be increased to >90%, with 5 mol % catalyst, by reducing temperature and increasing
reaction time (Supporting Information). Note that this formal halometalation/
carbocyclization bears some resemblance, particularly in the product structure, to Rh(I)-
mediated carbocyclizations reported by Zhang, that involve formal Alderene alkyne/allyl C-
H cycloisomerization16 or alkyne/allylic C-Cl condensation, with an accompanying halide
shift.17 The vinyl halide geometry obtained here is opposite that found in the Zhang
chemistry, and both the Rh catalyst (Rh(II)-perfluorocarboxylate/LiBr) and educts (allylic
carbonates) employed here also differ.
Subsequent RCM (Grubbs II catalyst)18 closes the bicyclo[4.3.1]decenyl linearifolin core.
The 3D-structure of the core was solved by x-ray crystallography which also served to
confirm absolute stereochemistry (Scheme 3). The antipodal series follows from the (R)-
epoxide obtained in the initial HKR of 5-benzyloxy-pentene oxide mediated by Co(III)-4a-
OAc (Scheme 1). The sequence mirrors that described for entry into the linearfolin core with
the exception that epoxide 9b, rather than a cyclic sulfate is opened by the lithiated
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propargyl ether, a reaction found to proceed optimally in the presence of F3B-OEt2 (Scheme
4). Here too, x-ray crystallography established 3D structure and absolute stereochemistry.
In the course of this investigation, it was also discovered that one could gain access to ring
contracted cores by RCM modification. Olefin isomerization is known to occasionally
accompany metathesis, presumably via the intermediacy of Ru-H species, as studied by
Schmidt,19 Grubbs20 and Snapper.21 This serves as an added benefit of this synthetic route,
with the Grubbs I catalyst22 giving ring contraction, and thereby access to the
oxabicyclo[3.3.1]nonyl core in zinagrandinolide23 and xerophilusin R24 (Scheme 5), both
antineoplastic natural products.23–24 Future studies will be directed at the further exploration
of this promising β-pinene-based salen scaffold in asymmetric catalysis, and this versatile
halocarbocyclization transformation, and at the deployment of these NP cores in chemical
biology.
Supplementary Material
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Figure 1.
Targeted Oxabicyclo[4.3.1]decyl SQL Cores
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Figure 2.
Retrosynthetic Analysis
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Figure 3.
ISES Readout on Salen-Set/New Reporting Enzymes
ISES screens for sense (+ S; − R) and magnitude of enantiopreference for Co(III)-salen-
mediated HKR with hexene oxide (purple) and propylene oxide (green) and 3a 1,2-
Diamines: 4 (β-pinene-derived); 5 (L-β-naphthyl-Ala-derived); 6 (L-Phe-derived); 7 (L-
phenyl-Gly-derived). Hydroxybenzaldehydes: a (α-hydroxy-β-naphthaldehyde); b (3,5-
diiodosalicylaldehyde); c (3-t-Bu-salicylaldehyde); d (3,5-di-t-Bu-salicylaldehyde). Note:
For entries 4c, 5b,c, 6a–d & 7a–d new reporting enzymes (KRED (Ketoreductase) 107 – S-
selective; KRED 119 R-selective) for the HKR of hexene oxide were employed.
Ginotra et al. Page 7
Org Lett. Author manuscript; available in PMC 2013 February 17.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Scheme 1.
HKR (salen 4a) Provides both SQL Building Blocks
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Scheme 2.
Convergent Assembly of the Halometalation/Carbocyclization Substrate
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Scheme 3.
Halometalation/Carbocyclization-RCM Sequence into the Linearifolin Core
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Scheme 4.
(R)-Epoxide Leads into the Zaluzanin A Core
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Scheme 5.
Isomerization-RCM: Oxabicyclo[3.3.1]nonyl Cores of Zinagrandinolide/Xerophilusin R
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Table 1
HKR of AcO-Co(III)-4a Across Potential Synthons
epoxide conv % ee; E-value (epoxide) % ee; E-Value (diol)
8
44% 52% (12) 80% (17)
9
47% 92% (182) 97% (183)
10
51% 93% (60) 90% (66)
11
44% 75% (97) 96%
Conditions: 1.3 mmol epoxide; 0.67 mmol H2O in 100 μL THF, with 2.5 mol % Co(III)-salen derived from 4a. Conversion estimated by NMR and
ee by HPLC-chiral stationery phase (Supporting Information).
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